OncoHost, a technology company focused on transforming the approach to precision oncology through proteomics and AI, announced on Thursday that it has been honoured as a Gold Winner in the 2025 Merit Awards for Healthcare, with recognition as Technology Solution of the Year.

The Merit Awards for Healthcare are designed to recognise companies delivering breakthrough technologies that meaningfully advance patient care.

OncoHost received top honours for its PROphet platform, an AI-powered, plasma-proteomics solution that predicts patient response to cancer therapy using a single pre-treatment blood sample.

Ofer Sharon, MD, OncoHost CEO, said: "This recognition from the Merit Awards highlights the meaningful clinical value the PROphet platform brings to cancer care. Our goal is to provide oncologists with clear, actionable insights that support more confident and informed treatment decisions from day one. We appreciate this acknowledgment of our team's ongoing work to advance precision oncology."